Aprepitant Relieves Refractory Chronic Pruritus

Idsk -- GOTHENBURG, Sweden (EGMN) – Patients with longstanding chronic pruritus refractory to the full array of conventional therapies had a high response rate to a neurokinin-1 receptor antagonist in a proof-of-concept study.